Lyme, Alpha-gal Syndrome, and other tick-borne diseases continue to pose serious public health challenges across the United States. Accurate and timely diagnostics are critical for effective treatment and prevention of long-term illness. This event will feature expert speakers who will provide key insights into the current state of diagnostic testing, emerging technologies, and policy opportunities to improve patient outcomes.
Event Details:
Topic: The Future of Lyme and Tick-borne Disease Diagnostics
Date: May 21, 2025
Time: 5:00 PM ET – 7:30 PM ET
Location: Senate Dirksen Office Building G50
Register to Meet with Representatives (Optional)
Agenda:
- Welcome
- Opening Remarks by U.S. Senator Susan Collins (Maine)
- Keynote: State of Lyme Disease Diagnostics Research – Nicole Bell, CEO Galaxy Diagnostics
- Expert Panel: LymeX Phase IV finalists
- Brandon Jutras, PhD, Associate Professor, Northwestern University
- Mark Junewicz, Founder and CEO, Gnomx
- Mary Ann Communale, EdD, MS, Associate Professor, Drexel University College of Medicine
- Nicole Bell, CEO, Galaxy Diagnostics
- Reception 6:30 – 7:30
This briefing will provide valuable information for policy staff working on health, science, appropriations, or related issues. Light refreshments will be provided.